Candidate : Actualité Candidate en direct - P2 | Bourse Reflex
Accueil > Tags > Candidate

  • Toutes les actualités en rapport avec « Candidate »

30/06 18:00 Candidate - Quantum Genomics Initiates Phase IIa trial for Heart Failure, the second strategic initiative for its BAPAI therapeutic platform

28/06 18:00 Candidate - Quantum Genomics extends its collaboration agreement with its partner in animal health

23/06 17:45 Candidate - GENTICEL REPORTS 18 MONTH INTERIM ANALYSIS OF GTL001 PHASE 2 TRIAL IN HPV16/18 INFECTED WOMEN

15/06 19:30 Candidate - GENTICEL TO PRESENT CLINICAL RESULTS OF GTL001 AND PRECLINICAL RESULTS OF GTL002 AT EUROGIN 2016 CONGRESS IN SALZBURG, AUSTRIA

13/06 18:35 Candidate - GENTICEL ANNOUNCES COMPLETION OF TWO MAJOR MILESTONES IN PREPARATION FOR PHASE 3 PROGRAM OF GTL001

08/06 18:35 Candidate - Disclosure of the total number of voting rights and shares composing the share capital

01/06 19:00 Candidate - GENTICEL ANNOUNCES PUBLICATION IN 'CLINICAL CANCER RESEARCH' OF PHASE 1 TRIAL RESULTS SUPPORTING SAFETY, TOLERABILITY AND IMMUNOGENICITY OF GTL001

31/05 18:00 Candidate - Quantum Genomics symposium at the European Meeting on Hypertension and Cardiovascular Protection

17/05 18:00 Candidate - Quantum Genomics granted two new U.S. patents covering lead product QGC001

11/05 08:00 Candidate - Disclosure of the total number of voting rights and shares composing the share capital

10/05 14:30 Candidate - BPI-labelled Artprice announces its Blockchain project for the Art Market.

28/04 18:35 Candidate - BUSINESS UPDATE - FIRST QUARTER 2016

26/04 18:35 Candidate - PUBLICATION OF THE 2015 ANNUAL FINANCIAL REPORT

21/04 19:45 Candidate - PUBLICATION OF THE FIRST ISSUE OF GENTICEL'S SHAREHOLDER NEWSLETTER

20/04 18:30 Candidate - GENTICEL REPORTS ADDITIONAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

14/04 18:00 Candidate - 2015 annual report : acceleration of clinical trials, secured financing and internationalisation in progress

06/04 18:00 Candidate - Disclosure of the total number of voting rights and shares composing the share capital

14/03 07:00 Candidate - GENTICEL ANNOUNCES 2015 ANNUAL RESULTS AND STRATEGIC UPDATE FOR 2016

10/03 18:30 Candidate - GENTICEL UPDATES ITS FINANCIAL CALENDAR FOR 2016 AND ANNOUNCES PARTICIPATION IN KEY CONFERENCES IN H1 2016

09/03 09:50 Candidate - Shaping the future of the ingredient industry with Naturex